Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Net-Receivables" stands at 158.71 Billion Japanese Yens as of 06/30/2025, the highest value since 06/30/2020.
As of the end of Kyowa Kirin Co Ltd's second quarter, the item "Net Receivables" stands at 158.71 Billion JPY. This represents an increase of 16.27 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.68 percent compared to the value the year prior.
The 1 year change in percent is 25.68.
The 3 year change in percent is 50.79.
The 5 year change in percent is 15.73.
The 10 year change in percent is -1.23.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Receivables | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Receivables | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Receivables | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Receivables | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Receivables | 280,205,508,085.11 |